Insights

Why Guardant Health Stock Was So Healthy Today

What happened

Friday was a good day to be a Guardant Health (NASDAQ: GH) shareholder. Thanks to an encouraging second-quarter report after market close on Thursday, investors embraced the oncology diagnostics specialist, buying into it enough to send the share price to a gain of almost 4%, in contrast to the slump of the S&P 500 index.

So what

That quarter saw Guardant Health earn slightly more than $109 million in revenue, a meaty 19% improvement over the same period of 2021. This was on the back of a 40% increase in tests to clinical consumers, and 65% growth in the number of tests to biopharmaceutical clients.

Going in the opposite direction was Guardant Health’s bottom line. On an adjusted basis, the company’s net loss for the quarter was nearly $102 million ($1 per share) against the $61 million shortfall of last year’s second quarter.

Still, the specialty healthcare company topped analyst expectations for both metrics. On average, those pundits had been expecting slightly over $105 million in revenue, and $1.21 per share as a net loss.

Guardant’s efforts were bolstered during the quarter by receiving Medicare coverage for its Guardant Reveal colorectal cancer diagnostic kit. The company quoted co-CEO Helmy Eltoukhy as saying, “We expect this to help fuel continued expansion as we look ahead to future product launches in the second half of the year.”

Now what

That optimism was reflected in Guardant’s full-year 2022 revenue guidance. The company anticipates it will take in $460 million to $470 million, which would mean 23% to 26% growth over 2021. It did not provide forecasts for any other line items.

Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Guardant Health. The Motley Fool has a disclosure policy.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

  • This field is for validation purposes and should be left unchanged.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Rebate Rewards

Level 2 Rebate

Deposit $2,000 and get $200 Rebate
$ 200 Rebate
  • 3 Simple Steps
  • 1. Register Using The Link Below (Promo-Code: WEBREBATE)
  • 2. Deposit $2,000 and place one trade at any non-Austalian market within 30 calendar days
  • 3. Receive Your $200 Rebate
Popular

Level 1 Rebate

Deposit $1,000 and get $100 Rebate
$ 100 Rebate
  • 3 Simple Steps
  • 1. Register Using The Link Below (Promo-Code: WEBREBATE)
  • 2. Deposit $1,000 and place one trade at any non-Austalian market within 30 calendar days
  • 3. Receive Your $100 Rebate

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;

To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.

An active and funded account with a positive trading balance is required to continue to have access to the tools;

Although the tools are available to you, Monex Securities may at it’s discretion disable access to the tools in the future;

Monex Securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

EASY QUALIFICATION & LOW ENTRY
NEW CLIENT REBATE OFFER
EARN UP TO $200 CASH REBATE
Act Fast - Promotion Ends In
Click Here To Get Started
EASY QUALIFICATION & LOW ENTRY
NEW CLIENT REBATE OFFER
EARN UP TO $200 CASH REBATE
Act Fast - Promotion Ends In
Click Here For More Info